4.4 Article

TRIM65 is a potential oncogenic protein via ERK1/2 on Jurkat and Raji cells: A therapeutic target in human lymphoma malignancies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

TRIM65 negatively regulates p53 through ubiquitination

Yang Li et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Review Biochemistry & Molecular Biology

Negative feedback regulation of the ERK1/2 MAPK pathway

David Lake et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2016)

Editorial Material Pharmacology & Pharmacy

Advances with microRNAs in Tumorigenesis and Cancer Therapy

Zhiwei Wang

CURRENT PHARMACEUTICAL DESIGN (2014)

Article Multidisciplinary Sciences

TRIM65 regulates microRNA activity by ubiquitination of TNRC6

Shitao Li et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Review Microbiology

Molecular hallmarks of adult T cell leukemia

Makoto Yamagishi et al.

FRONTIERS IN MICROBIOLOGY (2012)

Article Multidisciplinary Sciences

Trim24 targets endogenous p53 for degradation

Kendra Allton et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)